A vast and diverse health care giant, Johnson & Johnson strives to help people get well through its consumer products, pharmaceuticals, and medical devices.


Updates from The Motley Fool

Latest updates on Johnson & Johnson from Fool.com.  The Fool has written over 2300 articles on Johnson & Johnson.
Is Johnson & Johnson a Buy?

The healthcare giant has stumbled lately, but J&J still has plenty to offer investors.



Stock Performance

View Interactive JNJ Charts
Sponsored by

Key Data Points

Primary metrics and data points about Johnson & Johnson.
Current Price: $142.88
Prev Close: $142.88
Open: $142.18
Bid: $142.63
Ask: $142.90
Day's Range: $141.69 - $143.13
52wk Range: $118.62 - $148.32
Volume: 13,099,354
Avg Vol 5,497,084
Market Cap: $384B
P/E (ttm): 273.04
EPS (ttm): $0.52
Div & Yield: $3.36 (2.5%)

Company Rating

What our community thinks about Johnson & Johnson.
CAPS Rating 5 out of 5
 
13629 Outperform
506 Underperform
CAPS All Stars
 
2985 Outperform
58 Underperform

How do you think Johnson & Johnson will perform against the market?



You pick for Johnson & Johnson is winning

Score: +97.74
Call: Outperform
Time Frame: Five Plus Years
Start Price: $18.24
Start Date: 3/29/2007
Gain/Loss: +$152.4%
S&P Gain/Loss: +$54.7%

Powered by Motley Fool CAPS


CEO Rating

The single most important factor in a company's success is the team that's leading the company.

Alex Gorsky, CEO

95% Approve

Based on 1581 Ratings

Powered by Glassdoor

Business Summary

Industry, sector and description for Johnson & Johnson.

A vast and diverse health care giant, Johnson & Johnson strives to help people get well through its consumer products, pharmaceuticals, and medical devices.

  • Exchange: NYSE
  • Sector: Healthcare
  • Industry: Drug Makers